Viewing StudyNCT00034749



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00034749
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2002-05-02

Brief Title: The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Schizophrenia
Keywords:
Name View
risperidone View
Adolescents View
Schizophrenia View